Every intervention Outliyr has scored for healthy aging, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for healthy aging; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
64 of 100 evaluated interventions score 3.0+ out of 10 for healthy aging · 17 comparisons
Evidence for Essential Amino Acids in geriatric lands at 8.8/10 because Xie 2026 reports 9 RCTs; 496 participants; improved handgrip strength, gait speed, SPPB, and sit-to-stand with low-to-very-low certainty. Thavonlun 2026 points…
Read the Essential Amino Acids report →Glycine geriatric earns 8.5/10 because Soh 2024 anchors the most relevant signal. Glycine fits geriatric because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the endpoint. The…
Read the Glycine report →The geriatric use case receives an 8.0/10 score, reflecting strong responder potential in adults over 80 according to a systematic review of nursing-home residents Sanudo et al. 2024. Whole-Body Vibration may help…
Read the Whole-Body Vibration report →The geriatric case for Creatine Monohydrate is 7.6/10 because Chilibeck 2017 reports Older adults; +1.37 kg lean mass; leg press SMD 0.24. Van 2009 points in the same direction, but route, dose,…
Read the Creatine Monohydrate report →For geriatric, Zone 2 Cardio lands at 7.5/10 because Kodama 2009 supports the strongest part of the claim. The existing rationale points to this narrower claim: Moderate aerobic training is highly relevant…
Read the Zone 2 Cardio report →For geriatric, Blood-Flow Restriction Training lands at 7.5/10 because Lixandrao et al. 2018 supports the core mechanism. Centner 2019 found BFR increased strength and muscle mass in older adults, especially when heavy…
Read the Blood-Flow Restriction Training report →Full-Body EMS earns 7.5/10 for geriatric; this is a targeted fit score. Kemmler-group RCTs and the Yang 2022 sarcopenic-obesity meta-analysis support lean-mass and physical-function gains in older adults, while Bloeckl 2022 supports…
Read the Full-Body EMS report →Thymosin Alpha-1 geriatric earns 7.5/10 because Wu 2025 anchors the most relevant signal. Thymosin Alpha-1 fits geriatric when immune modulation is medically relevant and monitored rather than casually guessed. The score stays…
Read the Thymosin Alpha-1 report →On geriatric, Ca-AKG (Calcium Alpha-Ketoglutarate) deserves 7.5/10 because Filip 2007 makes the claim plausible but incomplete. The existing rationale points to this narrower claim: Cleanest responder profile is adults 50+ with lower…
Read the Ca-AKG (Calcium Alpha-Ketoglutarate) report →On geriatric, Spermidine deserves 7.2/10 because Schwarz 2022 makes the claim plausible but incomplete. The existing rationale points to this narrower claim: Older adults are the clearest target population across this verified…
Read the Spermidine report →The Norwegian 4x4 protocol receives a 7.0/10 rating for the geriatric use case, reflecting moderate evidence that older adults can achieve meaningful VO2max gains when training is progressive and medically screened Storen…
Read the Norwegian 4×4 report →Grass-Fed Whey Protein scores 6.8/10 for geriatric because older adults have higher protein needs and greater sarcopenia relevance. The strongest support comes from Shimomura Y. et al. 2006, but the practical rating…
Read the Grass-Fed Whey Protein report →Lion's Mane geriatric earns 6.8/10 because Menon 2025 anchors the most relevant signal. Lion's Mane fits geriatric when the goal is gentle mushroom-based support for cognition, mood, nerve biology, or gut-immune signaling…
Read the Lion’s Mane report →For readers tracking geriatric, HRV Biofeedback deserves 6.5/10 because Karavidas et al. 2007 gives the strongest anchor. Age-related HRV decline makes training especially relevant; positive small trials in older adults. The score…
Read the HRV Biofeedback report →For users targeting geriatric, Astaxanthin earns 6.5/10 because Liu 2024 reports 11 RCTs; 346 healthy participants; significant improvements reported across fatigue, cognition, and exercise-efficiency endpoints overall; endpoint details are limited. Laurindo 2025…
Read the Astaxanthin report →The evidence-weighted call is 6.5/10 for Phosphatidylserine in geriatric, led by Starks et al. 2008. Older adults are the primary target population. Crook 1991 and Cenacchi 1993 support the core signal, while…
Read the Phosphatidylserine report →Metformin scores 6.5/10 for the geriatric use case, reflecting moderate evidence from trials such as the UKPDS which showed mortality benefits in older overweight patients UK Prospective Diabetes Study Group 1998. Metformin…
Read the Metformin report →Mechanistically, Epitalon scores 6.5/10 for geriatric because the evidence points to a plausible use case without proving a universal response. Kozina et al. 2007 is the best anchor here because it reports…
Read the Epitalon report →The main limitation behind Saffron's 6.0/10 geriatric score is that the evidence points to a plausible use case without proving a universal response. Zhang et al. 2025 is the best anchor here…
Read the Saffron report →Older-adult use scores 6.0/10. Much of the KIHD cohort benefit accrued in middle-aged and older men followed into older age, and the cardiovascular, hypertension, and dementia associations from Laukkanen 2017 are exactly…
Read the Traditional Sauna (Finnish Dry-Heat) report →Geriatric is a 6.0/10 use case for Collagen Peptides, not a blanket claim. Strong target population. Koenig 2018 supports postmenopausal bone outcomes and Zdzieblik 2015 supports older men in resistance training. That…
Read the Collagen Peptides report →The evidence-weighted call is 6.0/10 for GHK-Cu in geriatric, led by Jose et al. 2014. Age-related decline in endogenous GHK and cellular repair signaling supports the preserved geriatric score, especially in older…
Read the GHK-Cu report →Tongkat Ali's 6.0/10 geriatric score starts with Tambi 2012, then gets narrowed by the evidence gap. The existing rationale points to this narrower claim: Age-related testosterone decline is the clearest responder profile.…
Read the Tongkat Ali report →Older adults are GlyNAC's home population and the case scores 6.0/10. Glutathione synthesis is documented to fall with age in Sekhar 2011, and correcting it produced functional gains: Kumar 2023 reported significant…
Read the GlyNAC (Glycine + N-Acetylcysteine) report →Tesamorelin reaches 6.0/10 for geriatric when the goal matches the population in Stanley et al. 2011. Tesamorelin targets an age-sensitive GH/IGF-1 axis and may improve VAT, cognition, and muscle quality in select…
Read the Tesamorelin report →Evidence for TRT (Testosterone Replacement Therapy) in geriatric lands at 6.0/10 because Resnick 2017 reports T Trials cognition substudy; null for memory and executive-function benefit. Snyder 2016 points in the same direction,…
Read the TRT (Testosterone Replacement Therapy) report →Older-adult cognition, telomere work, wound care, and radiation-injury data make geriatric one of the more relevant off-label slugs. Hadanny 2020 supports cognitive gains in adults age 64 and older after hard-chamber protocols.…
Read the Hyperbaric Oxygen Therapy report →Older adults score 5.5/10, one of the stronger non-core use cases. Vitamin C deficiency is more common in the elderly because of lower dietary intake, reduced appetite, and higher prevalence of smoking…
Read the Vitamin C (Ascorbic Acid) report →Shilajit geriatric earns 5.5/10 because Pandit 2016 anchors the most relevant signal. Shilajit fits geriatric when purified resin is matched to hormones, sperm parameters, strength fatigue, bone markers, or energy tracking. The…
Read the Shilajit report →Geriatric use scores 5.5 because two things that strongly predict independence in older adults, aerobic capacity and the ability to carry load, are exactly what a scalable loaded-walking protocol trains, and walking…
Read the Rucking (Weighted Walking) report →Berberine belongs in the 5.5/10 range for geriatric because the signal is conditional. Older adults may benefit metabolically, but polypharmacy raises the practical risk. Guo 2012 supports human CYP inhibition concerns relevant…
Read the Berberine report →Geriatric use earns 5.5/10 because aging is exactly where the associations cluster. Blood ergothioneine declines after age 60 per Cheah 2016, and low levels track with frailty in Kondoh 2022 and with…
Read the Ergothioneine report →The 5.5/10 geriatric score reflects evidence plus practical constraints. Older adults are the best-studied human group. Liu 2022 studied adults aged 65-90 and found muscle-endurance plus biomarker signals. That makes Urolithin A…
Read the Urolithin A report →NMN geriatric earns 5.5/10 because Zhang 2024 anchors the most relevant signal. NMN fits geriatric when raising NAD+ is likely to matter for older, metabolically stressed, or performance-tracking users. The score stays…
Read the NMN (Nicotinamide Mononucleotide) report →The main limitation behind SS-31 (Elamipretide)'s 5.5/10 geriatric score is that the evidence points to a plausible use case without proving a universal response. Ehlers JP et al. 2024 is the best…
Read the SS-31 (Elamipretide) report →The geriatric case for Electrolytes is 5.0/10 because Borra 2025 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: Older adults have higher dehydration risk due to…
Read the Electrolytes report →The strongest geriatric case puts L-Theanine at 5.0/10. Anxiety and sleep applications are relevant, and safety is clean, but older adults taking antihypertensives or sedatives should be more cautious. That makes L-Theanine…
Read the L-Theanine report →For readers prioritizing geriatric, Semax scores 5.0/10 today. Older adults are the most clinically relevant population because Semax evidence concentrates around stroke and neurorecovery, including Gusev et al. 2018, but Western geriatric…
Read the Semax report →Geriatric use scores 5.0/10. Older adults can gain real VO2max from interval work when intensity is scaled and medically screened, and even high-intensity intervals are well tolerated under supervision in older clinical…
Read the Sprinting (Sprint Interval Training) report →Mechanistically, Ashwagandha scores 5.0/10 for geriatric because the evidence points to a plausible use case without proving a universal response. Fatima et al. 2024 is the best anchor here because it reports…
Read the Ashwagandha report →The main limitation behind Omega-3's 5.0/10 geriatric score is that the evidence points to a plausible use case without proving a universal response. Abuknesha et al. 2025 is the best anchor here…
Read the Omega-3 report →The 5.0/10 geriatric score reflects evidence plus practical constraints. Geriatric relevance is stronger because endogenous MOTS-c changes with age and Reynolds 2021 tested late-life mouse physical-capacity effects. Human geriatric intervention trials remain…
Read the MOTS-c report →The practical geriatric read on NR (Nicotinamide Riboside) is 5.0/10 because Conze 2019 anchors the strongest signal. The existing rationale points to this narrower claim: Older adults have larger NAD+ decline, but…
Read the NR (Nicotinamide Riboside) report →Geriatric scoring is 5.0/10 because Semaglutide can help older adults with high obesity or diabetes risk, but sarcopenia risk makes casual use harder to justify. Perkovic 2024 supports kidney benefit in type…
Read the Semaglutide report →Older adults are the most plausible healthy-aging group, but benefits remain surrogate-based and risks rise with comorbidity and polypharmacy.
Read the Rapamycin report →Older adults are over-represented in the indications where Tβ4 has the most data (neurotrophic keratopathy, dry eye, chronic wounds, cardiac repair), and the safety record in older trial subjects is clean. No…
Read the Thymosin Beta-4 (Tβ4) report →Plausible for older adults given the cardiometabolic effects and complete protein, but dedicated trials in geriatric populations are sparse; sourcing caution matters more in vulnerable groups.
Read the Spirulina report →Older adults need caution because sarcopenia, bone density, cardiovascular disease, medication burden, and APOE status all matter. Keto can help supervised T2D and epilepsy cases, but Mediterranean-style patterns usually have stronger preventive-care…
Read the Ketogenic Diet report →Older adults with obesity, diabetes, OSA, or HFpEF may benefit. Frailty, sarcopenia, dehydration, constipation, polypharmacy, gallbladder risk, and bone risk are major limiters. Cap scoring unless protein, resistance training, medication review, and…
Read the Tirzepatide report →The cardiac and brain-fuel mechanisms are most interesting in older adults, and the heart-failure work (Nielsen 2019) involves an older population, but this remains clinical and investigational rather than a general geriatric…
Read the Exogenous Ketones report →Geriatric use is context-dependent. Older adults with impaired glucose tolerance or postmenopausal women with cerebrovascular/cognitive goals are the most plausible responders, supported indirectly by the impaired-glucose-tolerance pilot literature and directly by Thaung…
Read the Resveratrol report →An exercise mimetic could be useful for sedentary older adults if safe, but that is exactly the population where untested safety matters most. Bonanni et al. 2025 adds human myoblast pilot context,…
Read the SLU-PP-332 report →Healing acceleration is particularly valuable in aging populations. Older adults also face higher cancer, vascular, anticoagulation, and polypharmacy risk, so the caution bar is higher.
Read the BPC-157 report →Older-adult relevance comes through IPF, D plus Q, BP, and cohort signals such as Hertog 1993 and Nambiar 2023. Drug interaction concerns are amplified by polypharmacy and renal aging. Senolytic class pilots…
Read the Quercetin report →The clean safety profile and broad nutrient load make chlorella a reasonable food-based addition for older adults with borderline lipids, but no aging-population outcome trials specifically support it, so the case is…
Read the Chlorella report →The osteoarthritis and inflammation use cases are especially relevant to older adults, though the liver-injury caution matters more with polypharmacy.
Read the Curcumin report →Older adults are the population where glutathione decline is documented and the precursor trials showed effects, but glutathione monotherapy is unproven in this group, scoring 4.0/10.
Read the Glutathione (GSH) report →Babiloni-Lopez 2024 gave 93 older women microfiltered seawater alongside resistance training over 32 weeks with no adverse events and blood pressure that fell in training arms; the benefit tracked the exercise, not…
Read the Quinton Marine Plasma (Seawater Minerals) report →Widely used in older adults for arthritis, but NSAID cardiovascular, kidney, blood-pressure, and gastrointestinal risks are amplified with age. The geriatric score reflects utility plus elevated monitoring burden.
Read the Celebrex (Celecoxib) report →Older adults with obesity may benefit metabolically, but sarcopenia, frailty, dehydration, falls, polypharmacy, and appetite suppression make unsupervised use risky. No geriatric-specific retatrutide outcomes establish net benefit.
Read the Retatrutide report →Older adults may benefit indirectly from immune and gut support, but geriatric-specific evidence is limited. Duff 2014 is not enough to support a broad aging claim.
Read the Colostrum report →Gut and inflammatory uses are relevant to older adults, but the sodium load matters more with kidney or blood-pressure issues.
Read the Sodium Butyrate report →Modafinil geriatric use requires lower-dose caution and closer monitoring. DailyMed 2026 recommends considering lower doses and monitoring in geriatric patients. Score stays 3.0 because diagnosed sleepiness can justify use, but polypharmacy, cardiovascular…
Read the Modafinil report →No randomized C15:0 supplementation trial has tested adults over 65 against frailty, sarcopenia, cognitive decline, falls, or survival. Ciesielski 2024 (Ciesielski 2024) keeps the biology open rather than settled. Given unresolved cognitive-safety…
Read the C15 (Pentadecanoic Acid) report →Nothing matches those filters.
Head-to-head reports and category rankings that name a winner on this use case.
Tesamorelin, at 6.2, and only if you have a clinical reason. Every one of the nine scores 6.2 or lower, so the category tops out at worth trying…
Cerebrolysin scores 6.3 and P-21 scores 5.0, and the gap is entirely about human data. Cerebrolysin has thousands of trial participants, contested by two independent Cochrane reviews. P-21…
Tesamorelin, unless price is the only thing deciding. It is FDA-approved for visceral fat with Phase 3 trials behind it, while CJC-1295 is a gray-market research peptide whose…
These two get sold as the same thing, a scoop for gut and skin, and they share almost no mechanism. Colostrum is a gut and immune product: gut…
Epitalon, if sleep is the question. It scores sleep quality 6.5 against pinealon's 1.7, because it acts on the pineal gland and melatonin output while pinealon is a…
No, and the reason is mechanical. A drink raises blood ketones in an hour. It does not lower insulin, deplete glycogen or shift fuel use. The diet scores…
Start on sermorelin. Ipamorelin scores higher overall, yet sermorelin wins thirteen of the sixteen shared use cases and it is the one an anti-aging clinic actually prescribes. Ipamorelin…
Spermidine scores 7.6 and urolithin A 6.5, and they clean up different messes. Spermidine drives broad autophagy: autophagy 8.0, cardiovascular 7.8, longevity 7.5. Urolithin A drives selective mitophagy…
Thymulin scores 6.6, thymalin 5.9, and they are not interchangeable. Thymulin is a defined zinc-dependent peptide with receptor-level science, stronger inflammation data and a much cheaper course. Thymalin…
Semax scores 7.1 and cerebrolysin 6.3. Semax wins cognition, neuroplasticity and nerve regeneration, costs an ESTIMATED $12 to $60 a month, and goes up your nose. Cerebrolysin wins…
Semax scores 7.1 against dihexa's 4.4, and that gap is real. Semax wins every cognitive use case we scored and carries human stroke data. Dihexa has zero human…
GHRP-2 scores 5.5 and GHRP-6 scores 5.1. Both are ghrelin-receptor peptides doing the same job, and appetite is the only difference that changes a decision. Pick GHRP-2 for…
Essential Amino Acids, at 8.8 out of 10 for healthy aging. Evidence for Essential Amino Acids in geriatric lands at 8.8/10 because Xie 2026 reports 9 RCTs; 496 participants; improved handgrip strength, gait speed, SPPB, and sit-to-stand with low-to-very-low certainty.
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 8.5 out of 10 for healthy aging.
64 of the 100 interventions evaluated for healthy aging score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
